[Treatment of hematopoietic proliferative syndromes with a semi-synthetic podophyllin derivative].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D004357:Drug Synergism; D005069:Evaluation Studies as Topic; D006027:Glycosides / Q000627:therapeutic use; D006410:Hematopoiesis; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D007938:Leukemia / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008875:Middle Aged; D011033:Podophyllin / Q000627:therapeutic use*; D013577:Syndrome; D013876:Thiophenes / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D006027:Glycosides; D007783:Lactones; D013876:Thiophenes; D011033:Podophyllin
Próby leczenia zespołów rozrostowych ukłladu krwitotórczego półsyntetyczna pochodna podofiliny.